About
Technology
Issues
FAQ
Links
Official Page
A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic vaccine with
Candida
skin test reagent as a novel vaccine adjuvant for treating women with biopsy-proven cervical intraepithelial neoplasia 2/3
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.